查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595115

骨關節炎治療藥物市場：依解剖結構、藥物類型、給藥途徑、採購模式、通路 - 2025-2030 年全球預測

Osteoarthritis Therapeutics Market by Anatomy, Drug Type, Route of Administration, Purchasing Pattern, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年骨關節炎藥物市值為79億美元，預計2024年將達到86.9億美元，複合年成長率為10.39%，預計到2030年將達到157.8億美元。

骨關節炎藥物是指旨在減輕骨關節炎症狀並減緩其進展的治療方法，骨關節炎是一種以軟骨破壞為特徵的退化性關節疾病。這些包括但不限於非類固醇抗發炎藥、皮質類固醇、止痛藥、生物製藥等藥物，以及基因療法和幹細胞療法等新治療方法。由於人口老化、肥胖率增加和生活方式的改變，全球骨關節炎盛行率不斷上升，推動了對這些治療方法的需求。這些治療旨在減輕疼痛和發炎並改善關節功能，主要用於受影響個體的診所、醫院和家庭保健。市場成長受到技術進步、研發投資增加以及早期復健意識提高的影響。此外，聯合治療和微創手術的發展也帶來了巨大的機會。公司可以透過投資創新技術並透過策略聯盟和收購擴大產品系列來增加資本。然而，高昂的治療成本、嚴格的監管要求和潛在的副作用限制了市場的擴張。創新和研究應著重於開發具有成本效益、患者友善且副作用較少的標靶治療。在藥物發現中利用人工智慧和機器學習並開發針對個別患者情況的個人化醫療可以提供競爭優勢。市場格局是動態的，其特徵是快速發展和需要不斷適應的競爭格局。投資先進研究以了解疾病機制和改善輸送系統的公司可能會成功。雖然市場前景廣闊，但必須克服監管挑戰，以確保能夠負擔得起更廣泛的患者群體，並促進骨關節炎管理的更廣泛的獲取和教育，這凸顯了與政府機構和醫療機構合作的必要性。

主要市場統計
基準年[2023] 79億美元
預測年份 [2024] 86.9億美元
預測年份 [2030] 157.8億美元
複合年成長率（%） 10.39%

市場動態：揭示快速發展的骨關節炎藥物市場的關鍵市場洞察

供需的動態交互作用正在改變骨關節炎藥物市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球骨關節炎盛行率不斷上升
    • 微創手術的潛在需求
    • 隨著世界各地運動傷害的增加，老年人口也在增加。
  • 市場限制因素
    • 對 NSAID 副作用的擔憂
  • 市場機會
    • 治療骨關節炎的新藥物療法
    • 骨關節炎領域的持續研究與開發
    • 政府加強對骨關節炎治療的支持
    • 新興國家人均醫療費用增加
  • 市場挑戰
    • 非藥物疼痛管理療法的快速傳播

波特五力：駕馭骨關節炎藥物市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對骨關節炎藥物市場的影響

外部宏觀環境因素在塑造骨關節炎治療藥物市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解骨關節炎治療藥物市場的競爭狀況

對骨關節炎治療藥物市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣骨關節炎藥物市場供應商的績效評估

FPNV定位矩陣是評估骨關節炎藥物市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪骨關節炎藥物市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對骨關節炎治療藥物市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的骨關節炎盛行率正在上升
      • 微創手術的潛在需求
      • 全球人口老化加劇和運動傷害數量增加
    • 抑制因素
      • 對 NSAID 副作用的擔憂
    • 機會
      • 治療方法骨關節炎的新藥物
      • 在骨關節炎領域持續研究和開發
      • 加強政府對骨關節炎治療的支持
      • 新興國家人均醫療費用上升
    • 任務
      • 快速引入非藥物疼痛管理療法
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章骨關節炎治療藥物市場剖析

  • 手骨關節炎
  • 髖骨關節炎
  • 膝骨關節炎
  • 小關節骨關節炎

第7章依藥物類型分類的骨關節炎治療市場

  • 止痛藥
    • 乙醯胺酚
    • Duloxetine
  • 皮質類固醇
  • 非類固醇消炎劑
    • 阿斯匹靈
    • 雙氯芬酸鈉
    • Ibuprofen
    • 萘普生
  • 關節內粘稠補充療法劑

第8章骨關節炎治療藥物市場：依給藥途徑

  • 口服給藥
  • 腸外給藥
  • 局部途徑

第9章骨關節炎治療藥物市場（依購買模式）

  • 非處方藥
  • 處方藥

第10章骨關節炎治療藥物市場：按分銷管道

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第11章北美和南美的骨關節炎治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太骨關節炎治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲骨關節炎治療藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Almatica Pharma LLC
  • Anika Therapeutics, Inc.
  • Assertio Therapeutics, Inc.
  • Atnahs Pharma UK Limited
  • Bayer AG
  • Bioventus
  • Eli Lilly and Company
  • Ferring BV
  • Fidia Farmaceutici spa
  • Flexion Therapeutics, Inc.
  • GlaxoSmithKline PLC
  • Hanmi Pharm. Co., Ltd.
  • Horizon Therapeutics PLC
  • Kitov Pharmaceuticals Ltd.
Product Code: MRR-DD6333AE50BA

The Osteoarthritis Therapeutics Market was valued at USD 7.90 billion in 2023, expected to reach USD 8.69 billion in 2024, and is projected to grow at a CAGR of 10.39%, to USD 15.78 billion by 2030.

Osteoarthritis therapeutics refer to a wide array of treatments designed to alleviate the symptoms and slow the progression of osteoarthritis, a degenerative joint disease characterized by the breakdown of cartilage. The scope includes but is not limited to pharmaceuticals like NSAIDs, corticosteroids, and analgesics, biologics, and emerging therapies such as gene therapy and stem cell treatment. The necessity for these therapeutics arises from the growing prevalence of osteoarthritis worldwide, driven by an aging population, increased obesity rates, and lifestyle changes. These therapeutics find application in reducing pain, inflammation, and improving joint function, primarily targeting affected individuals for use at clinics, hospitals, and home healthcare settings. Market growth is influenced by technological advancements, increasing R&D investments, and a rising awareness of early rehabilitation. Furthermore, the development of combination therapies and minimally invasive procedures present significant opportunities. Companies can capitalize by investing in innovative technologies and expanding their product portfolios through strategic partnerships and acquisitions. However, high treatment costs, stringent regulatory requirements, and potential side effects present limitations to market expansion. Innovation and research should focus on developing cost-effective, patient-friendly, and targeted treatment options with reduced side effects. Leveraging AI and machine learning for drug discovery and developing personalized medicine tailored to individual patient profiles could offer competitive advantages. The osteoarthritis therapeutics market is dynamic, characterized by rapid advancements and a competitive landscape necessitating constant adaptation. Companies investing in advanced research to understand the disease mechanisms and improve delivery systems will likely thrive. While promising, the market requires navigating regulatory challenges and ensuring affordability to reach a broader patient base, underscoring the need for collaboration with government bodies and healthcare institutions to facilitate widespread access and education on osteoarthritis management.

KEY MARKET STATISTICS
Base Year [2023] USD 7.90 billion
Estimated Year [2024] USD 8.69 billion
Forecast Year [2030] USD 15.78 billion
CAGR (%) 10.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Osteoarthritis Therapeutics Market

The Osteoarthritis Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of osteoarthritis across the globe
    • Potential demand for minimally invasive surgical procedures
    • Growing geriatric population coupled with increasing sports injury worldwide
  • Market Restraints
    • Concern associated with adverse effects of NSAID
  • Market Opportunities
    • Emerging pharmaceuticals therapies for osteoarthritis
    • Ongoing research and development in the osteoarthritis field
    • Increasing governments supports towards the osteoarthritis treatment
    • Rising healthcare expenditure per capita income in the emerging economies
  • Market Challenges
    • Rapid adoption of non-drug pain management therapies

Porter's Five Forces: A Strategic Tool for Navigating the Osteoarthritis Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Osteoarthritis Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Osteoarthritis Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Osteoarthritis Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Osteoarthritis Therapeutics Market

A detailed market share analysis in the Osteoarthritis Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Osteoarthritis Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Osteoarthritis Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Osteoarthritis Therapeutics Market

A strategic analysis of the Osteoarthritis Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Osteoarthritis Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Almatica Pharma LLC, Anika Therapeutics, Inc., Assertio Therapeutics, Inc., Atnahs Pharma UK Limited, Bayer AG, Bioventus, Eli Lilly and Company, Ferring B.V., Fidia Farmaceutici s.p.a., Flexion Therapeutics, Inc., GlaxoSmithKline PLC, Hanmi Pharm. Co., Ltd., Horizon Therapeutics PLC, and Kitov Pharmaceuticals Ltd..

Market Segmentation & Coverage

This research report categorizes the Osteoarthritis Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Anatomy, market is studied across Hand Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, and Small Joint Osteoarthritis.
  • Based on Drug Type, market is studied across Analgesics, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs, and Viscosupplementation Agents. The Analgesics is further studied across Acetaminophen and Duloxetine. The Nonsteroidal Anti-inflammatory Drugs is further studied across Aspirin, Diclofenac, Ibuprofen, and Naproxen.
  • Based on Route of Administration, market is studied across Oral Route, Parenteral Route, and Topical Route.
  • Based on Purchasing Pattern, market is studied across Over-the-Counter Drugs and Prescription Drugs.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of osteoarthritis across the globe
      • 5.1.1.2. Potential demand for minimally invasive surgical procedures
      • 5.1.1.3. Growing geriatric population coupled with increasing sports injury worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with adverse effects of NSAID
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging pharmaceuticals therapies for osteoarthritis
      • 5.1.3.2. Ongoing research and development in the osteoarthritis field
      • 5.1.3.3. Increasing governments supports towards the osteoarthritis treatment
      • 5.1.3.4. Rising healthcare expenditure per capita income in the emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Rapid adoption of non-drug pain management therapies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Osteoarthritis Therapeutics Market, by Anatomy

  • 6.1. Introduction
  • 6.2. Hand Osteoarthritis
  • 6.3. Hip Osteoarthritis
  • 6.4. Knee Osteoarthritis
  • 6.5. Small Joint Osteoarthritis

7. Osteoarthritis Therapeutics Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Analgesics
    • 7.2.1. Acetaminophen
    • 7.2.2. Duloxetine
  • 7.3. Corticosteroids
  • 7.4. Nonsteroidal Anti-inflammatory Drugs
    • 7.4.1. Aspirin
    • 7.4.2. Diclofenac
    • 7.4.3. Ibuprofen
    • 7.4.4. Naproxen
  • 7.5. Viscosupplementation Agents

8. Osteoarthritis Therapeutics Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral Route
  • 8.3. Parenteral Route
  • 8.4. Topical Route

9. Osteoarthritis Therapeutics Market, by Purchasing Pattern

  • 9.1. Introduction
  • 9.2. Over-the-Counter Drugs
  • 9.3. Prescription Drugs

10. Osteoarthritis Therapeutics Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacies
  • 10.3. Online Pharmacies
  • 10.4. Retail Pharmacies

11. Americas Osteoarthritis Therapeutics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Osteoarthritis Therapeutics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Osteoarthritis Therapeutics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Almatica Pharma LLC
  • 3. Anika Therapeutics, Inc.
  • 4. Assertio Therapeutics, Inc.
  • 5. Atnahs Pharma UK Limited
  • 6. Bayer AG
  • 7. Bioventus
  • 8. Eli Lilly and Company
  • 9. Ferring B.V.
  • 10. Fidia Farmaceutici s.p.a.
  • 11. Flexion Therapeutics, Inc.
  • 12. GlaxoSmithKline PLC
  • 13. Hanmi Pharm. Co., Ltd.
  • 14. Horizon Therapeutics PLC
  • 15. Kitov Pharmaceuticals Ltd.

LIST OF FIGURES

  • FIGURE 1. OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. OSTEOARTHRITIS THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. OSTEOARTHRITIS THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OSTEOARTHRITIS THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OSTEOARTHRITIS THERAPEUTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SMALL JOINT OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DULOXETINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DICLOFENAC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY IBUPROFEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NAPROXEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY VISCOSUPPLEMENTATION AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ORAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PARENTERAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TOPICAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANA